Q2 2024 Intuitive Surgical Inc Earnings Call Transcript
Key Points
- Intuitive Surgical Inc (ISRG) reported a solid 17% growth in procedures for Q2 2024 compared to Q2 2023.
- The company placed 341 da Vinci systems in the quarter, including 70 da Vinci 5 systems, indicating strong demand for new technology.
- Revenue growth of 14% in the quarter was driven by solid procedure performance and strong capital placements.
- Product margins exceeded expectations due to cost reductions, fixed overhead leverage, and some one-time nonrecurring benefits.
- Adoption of digital products and services grew significantly, with the My Intuitive app expanding to nearly 14,000 surgeons.
- Multi-port procedural headwinds continued from the previous quarter, impacting overall performance.
- System utilization growth of 2% globally was lower than historical trends, reflecting the previous year's procedure strength due to patient backlog.
- Bariatric procedures in the US declined in the mid-single digit range, indicating a potential area of concern.
- Capital placements in Europe and China faced pressure due to health system budget constraints and emerging domestic robotic systems.
- The operating environment in China remains challenging due to anti-corruption initiatives and economic rebasing, impacting capital placements and procedure growth.
Thank you, everyone, for standing by, and welcome to the Intuitive second-quarter 2024 earnings release. (Operator Instructions) As a reminder, today's call is being recorded. I will now turn the call over to your host, Head of Investor Relations, Brian King. Please go ahead.
Good afternoon, and welcome to Intuitive second-quarter earnings conference call. With me today, we have Gary Guthart, our CEO; Dave Rosa, our President; and Jamie Samath, our CFO.
Before we begin, I would like to inform you that comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K for the fiscal year ended December 31, 2023, and subsequent filings.
Our SEC filings can be found through our website or at the SEC's website
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
